Üsküdar Üniversitesi's BrainPark Incubation Center established ALEA, a company that aims to provide solutions in the healthcare sector with wearable neurotechnology products. With the bracelet produced by the company, it is aimed to prevent tremors in the treatment of 'tremor' disease and to improve the individual's quality of life. Prof. Dr. Sultan Tarlacı, co-founder of the company, stated that they are also developing products for neurological diseases such as epilepsy, migraine, depression, ulcerative colitis, hypertension, diabetes, and tinnitus (ringing in the ears).
ALEA, an entrepreneurial company of Üsküdar Üniversitesi BrainPark Incubation Center, has started producing wearable technology products
With the support of BrainPark TTO, ALEA Neurotechnology and R&D Inc., established within Üsküdar Üniversitesi BrainPark Incubation Center, aims to provide services particularly in the field of wearable neurotechnology.
The special bracelet developed by ALEA, founded under the leadership of Prof. Dr. Sultan Tarlacı, Head of the Neuroscience Department at Üsküdar Üniversitesi Faculty of Medicine, and his team, Pusat Furkan Doğan and Metehan Kaya, offers a treatment option for the hand tremor disease known as "tremor."
Bracelet designed to prevent hand tremors
The ALEA company is conducting studies for the treatment of hand tremor disease, known as "tremor." Tremor, a disease that makes eating and drinking difficult for individuals, disrupts daily activities, causes weakness in writing and using tools, and leads to difficulties such as fatigue and loss of balance, reduces an individual's quality of life. With the damping bracelet designed by ALEA, the aim is to reduce tremor, prevent shaking without adding weight to the patient, and offer the patient a high quality of life.
First Domestic Product in Turkey for the Treatment of Tremor Disease
ALEA, which has no competitor in Turkey for the treatment of Tremor Disease in the field of wearable neurotechnology, stands out in the sector with both its price and the features it offers. Preparing to open up to the global market, ALEA comes to the forefront with its practical and cost-effective solution proposal.
Prof. Dr. Sultan Tarlacı: “We aim to treat tremor”
Prof. Dr. Sultan Tarlacı, Co-founder of ALEA Neurotechnology and R&D Inc., stated that they aim to treat tremors caused by various reasons such as aging, stress, hyperthyroidism, stroke, trauma, and Parkinson's, and to improve the patient's quality of life.
Prof. Dr. Sultan Tarlacı said, "We observed that tremors occurring in limbs, regardless of age and gender, reduce the quality of life, and people who try to cope with many problems due to these tremors are more depressed. With the bracelet we developed, we aim to reduce tremors and improve the quality of life."
ALEA will treat many diseases with wearable products
Prof. Dr. Tarlacı stated that they plan to offer treatment options for many diseases with wearable neurological products, saying, "For now, we started with just a wristband, and we will continue our journey with wearable technologies that will improve tremors in other limbs. In addition, we will soon introduce the products we developed for neurological diseases such as epilepsy, migraine, depression, ulcerative colitis, atrial fibrillation, hypertension, diabetes, and tinnitus (ringing in the ears). We established our company at Üsküdar Üniversitesi BrainPark Incubation Center. We are very pleased to collaborate with our Incubation Center on commercialization, investment, and global expansion, and for the support they provide. We are proud to offer practical and affordable wearable technology in local and global markets."